PPRE-H2B-eGFP Citations (2)
Originally described in: New Transcriptional Reporters to Quantify and Monitor PPARgamma Activity.Degrelle SA, Shoaito H, Fournier T PPAR Res. 2017;2017:6139107. doi: 10.1155/2017/6139107. Epub 2017 Nov 1. PubMed Journal
Articles Citing PPRE-H2B-eGFP
| Articles |
|---|
| Peroxisome proliferator-activated receptor gamma-ligand-binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration. Shoaito H, Chauveau S, Gosseaume C, Bourguet W, Vigouroux C, Vatier C, Pienkowski C, Fournier T, Degrelle SA. J Cell Mol Med. 2020 Jul;24(13):7660-7669. doi: 10.1111/jcmm.15401. Epub 2020 Jun 9. PubMed |
| Off-target engagement of sotorasib with PPARgamma via FABP4: a novel mechanism driving interstitial lung disease. Zhang J, Li J, Cheng M, Zhou H, Zhang X, Yan H, Xu Z, Yang B, He Q, Gao Z, Chen X, Luo P. Cell Commun Signal. 2025 Oct 2;23(1):416. doi: 10.1186/s12964-025-02425-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.